AffinityImmuno presents as one of top three finalists at virtual BioInnovation Challenge pitch event

On November 4, during BioPort 2020, Amir Zuccolo, Director of Quality at AffinityImmuno presented as one of the top three finalists competing in the 10th annual BioInnovation Challenge (BIC), BioNova’s regional health and life sciences business competition. AffinityImmuno has been a client of Emergence: Canada’s Bioscience Business Incubator since 2016.

BIC is one of the longest running business competitions in the region with over 50 companies having gone through the program since 2011. Many of the companies coming out of the program have gone on to raise millions to grow and scale. 

AffinityImmuno was first named as one of the eight semi-finalists in August 2020, and received training to be positioned for business growth, including sessions with expert pitch training coach Linda Plano, who has over ten years of experience mentoring entrepreneurs with start-ups in life sciences. Resulting in an admirable third-place finish, AffinityImmuno will receive $2,500 worth of in-kind services from Grant Thornton.

AffinityImmuno has developed a novel serum test to meet the challenge of monitoring development of immunity to the ongoing SARS-CoV-2 pandemic. The virus neutralization test monitors vaccine responses, population spread of a virus, and length of immune response.

For more information on AffinityImmuno, visit affinityimmuno.com.

This entry was posted in Clients. Bookmark the permalink.